CVXL-0074

N/A

Report date: 2025/01/26 17:47:19
NME

Base Information

Drug NameCVXL-0074
Drug Alias NameCPh-1012SYK/JAK inhibitor (Dynamix/CleveXel)CVXL-0074
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionJanus kinase inhibitorsSpleen tyrosine kinase inhibitors
TargetsJanus kinaseSpleen tyrosine kinase
Therapy Area/IndicationsImmune System DiseasesSkin DiseasesDermatitis, Atopic +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFranceIsrael
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDynamix Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDynamix Pharmaceuticals LtdClevexel Pharma
Inactive CompaniesN/A
Active IndicationsSkin DiseasesDermatitis, AtopicArthritis, Rheumatoid
Inactive IndicationsImmune System DiseasesRespiratory Tract Diseases

Other Information

ATC CodeN/A
Related LinksN/A